HKPD
Income statement / Annual
Last year (2025), Hong Kong Pharma Digital Technology Holdings Limited's total revenue was $20.31 M,
an increase of 21.72% from the previous year.
In 2025, Hong Kong Pharma Digital Technology Holdings Limited's net income was -$27.06 K.
See Hong Kong Pharma Digital Technology Holdings Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
| Period Ended |
03/31/2025 |
03/31/2024 |
03/31/2023 |
| Operating Revenue |
$20.31 M |
$16.69 M |
$12.56 M |
| Cost of Revenue |
$17.90 M
|
$13.13 M
|
$9.82 M
|
| Gross Profit |
$2.42 M
|
$3.56 M
|
$2.74 M
|
| Gross Profit Ratio |
0.12
|
0.21
|
0.22
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.22 M
|
$1.89 M
|
$1.76 M
|
| Other Expenses |
$67.26 K
|
$60.95 K
|
-$62.95 K
|
| Operating Expenses |
$2.28 M
|
$1.95 M
|
$1.70 M
|
| Cost And Expenses |
$20.18 M
|
$15.08 M
|
$11.51 M
|
| Interest Income |
$1.74 K
|
$474.00
|
$219.00
|
| Interest Expense |
$97.67 K
|
$82.77 K
|
$23.24 K
|
| Depreciation & Amortization |
$1.07 M
|
$925.58 K
|
$714.59 K
|
| EBITDA |
$1.21 M |
$2.53 M |
$1.76 M |
| EBITDA Ratio |
0.06
|
0.15
|
0.14
|
| Operating Income Ratio |
0.01
|
0.1
|
0.08
|
| Total Other Income/Expenses Net |
-$95.93 K
|
-$82.29 K
|
-$23.02 K
|
| Income Before Tax |
$36.11 K
|
$1.53 M
|
$1.02 M
|
| Income Before Tax Ratio |
0
|
0.09
|
0.08
|
| Income Tax Expense |
$63.17 K
|
$196.25 K
|
$22.57 K
|
| Net Income |
-$27.06 K
|
$1.33 M
|
$998.20 K
|
| Net Income Ratio |
-0
|
0.08
|
0.08
|
| EPS |
-0.0027 |
0.18 |
0.0907 |
| EPS Diluted |
-0.003 |
0.18 |
0.0907 |
| Weighted Average Shares Out |
$9.02 M
|
$7.37 M
|
$11.00 M
|
| Weighted Average Shares Out Diluted |
$10.21 M
|
$7.37 M
|
$11.00 M
|
| Link |
|
|
|
